基本信息
浏览量:122
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Walter Moos is a Managing Director of Pandect Bioventures, which he co-founded in 2018. Starting in 2016, first as an advisor and then as CEO and as Chairman emeritus of ShangPharma Innovation, he led development of the group's innovation ecosystem. Moos has been an adjunct Professor of Pharmaceutical Chemistry at UCSF since 1992. He was President of SRI Biosciences until 2016 after more than a decade at the independent nonprofit SRI International (Stanford Research Institute). Moos also managed corporate Information Technology Services at SRI. Earlier he was Chairman/CEO of MitoKor (Migenix) and a VP at Chiron (Novartis) and at Warner-Lambert/Parke-Davis (Pfizer). He and his teams have made significant contributions to all R&D phases from early-stage research on chemical and biological therapeutics and diagnostics to marketed pharmaceutical products. They have done this with the support of VCs, foundations, government agencies, big pharma, and many others. Moos has served on more than 20 business and scientific boards, public and private, non-profit and for-profit, including Alnis, Amunix, Anterion, Aprinoia, Axiom (Sequenom), the Biotechnology Industry Organization (BIO), Circle, the Critical Path Institute, Global Blood, Keystone Symposia, Migenix, Mimotopes (Fisher/Thermo), MitoKor, Oncologic (Aduro/Chinook), Onyx (Amgen), Rigel, ShangPharma Innovation, and Valitor. He has advised companies on several continents and served as a committee member for academic, government, and investor groups, including the US National Academy of Sciences. He has co-founded several scientific journals, co-authored or edited 6 books, and has approximately 200 patents and publications. Moos has held faculty positions at several major universities and received PhD and AB degrees in chemistry from UC Berkeley and Harvard, respectively.
研究兴趣
论文共 223 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Elsevier eBookspp.3-26, (2023)
Elsevier eBookspp.531-537, (2023)
Elsevier eBookspp.27-64, (2023)
Elsevier eBookspp.157-168, (2023)
Elsevier eBookspp.575-615, (2023)
Managing the Drug Discovery Processpp.513-527, (2023)
Managing the Drug Discovery Processpp.339-415, (2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn